| Fungal contamination shuts down NIH drug manufacturing facility
The National Institutes of Health has halted operations at one of its drug manufacturing facilities after fungus was discovered in two vials of a blood protein. READ MORE
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, June 5, 2015
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment